ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,316Medicare Part D Prescriptions Filled, Including Refills

Rank: 159 out of 617

$346K Total Retail Price of All Prescriptions

Rank: 195 out of 617

284 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 284 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 284 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 6,562 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 383 311 1 1
OMEPRAZOLE 347 258 2 3
SIMVASTATIN 334 265 3 2
FUROSEMIDE 253 227 4 4
METFORMIN HCL 212 167 5 9
METOPROLOL TARTRATE 210 202 6 11
WARFARIN SODIUM 202 189 7 7
LISINOPRIL 197 138 8 5
GABAPENTIN 189 138 9 16
POTASSIUM CHLORIDE 181 159 10 10
AMLODIPINE BESYLATE 181 163 10 6
HYDROCODONE-ACETAMINOPHEN 155 104 S3 12 8
CITALOPRAM HBR 143 124 13 18
MELOXICAM 121 82 14 24
LOSARTAN POTASSIUM 120 101 15 22
ALENDRONATE SODIUM 117 96 16 25
TAMSULOSIN HCL 112 107 17 26
RANITIDINE HCL 105 91 18 40
TRAZODONE HCL 99 56 19 51
ALLOPURINOL 98 97 20 27
TRAMADOL HCL 96 62 21 15
POLYETHYLENE GLYCOL 3350 88 80 22 32
NAMENDA 84 84 23 35
CYMBALTA 83 75 24 49
HYDROCHLOROTHIAZIDE 72 69 25 13
LOVASTATIN 68 49 26 57
CRESTOR 68 57 26 28
CARVEDILOL 68 59 26 19
DOXAZOSIN MESYLATE 66 57 29 79
ATENOLOL 66 59 29 17
BYSTOLIC 64 55 31 64
ENALAPRIL MALEATE 63 63 32 34
DILTIAZEM 24HR ER 63 55 32 162
SUCRALFATE 62 43 34 143
ISOSORBIDE MONONITRATE ER 62 62 34 52
TRIAMTERENE-HCTZ 61 61 36 47
LOSARTAN-HYDROCHLOROTHIAZIDE 56 54 37 46
PROPRANOLOL HCL 53 18 38 109
DONEPEZIL HCL 53 53 38 30
ZOLPIDEM TARTRATE 52 39 40 23
GLIPIZIDE ER 50 38 41 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.